Mutagenicity testing of diethylene glycol monobutyl ether. by Thompson, E D et al.
Environmental Health Perspectives
Vol. 57, pp. 105-112, 1984
Mutagenicity Testing of
Diethylene Glycol Monobutyl Ether
by Edward D. Thompson,*t Walter J. Coppinger,*
Ruby Valencia* and Joe lavicoli*
The mutagenic potential of diethylene glycol monobutyl ether (diEGBE) was examined with a Tier I
battery of in vitro assays followed by a Tier II in vivo Drosophila sex-linked recessive lethal assay. The in
vitro battery consisted of: the Salmonella mutagenicity test, the L5178Y mouse lymphoma test, a
cytogenetics assay using Chinese hamster ovary cells and the unscheduled DNA synthesis (UDS) assay in
rat hepatocytes. Results ofthe Salmonella mutagenicity test, the cytogenetics test, and the rat hepatocyte
assay were negative at concentrations up to 20 FL/plate, 7.92 ,uL/mL, and 4.4 ,uL/mL, respectively. Toxicity
was clearly demonstrated at all high doses. A weak, but dose-related increase in the mutation frequency
(4-fold increase over the solvent control at 5.6 UL/mL with 12% survival) was obtained in the L5178Y
lymphoma test in the absence ofmetabolic activation. Results ofthe mouse lymphoma assay were negative
in the presence of the S-9 activation system. The significance of the mouse lymphoma assay results were
assessed by performing the Tier II sex-linked recessive lethal assay in Drosophila in which the target tissue
is maturing germinal cells. Both feeding (11,000 ppm for 3 days) and injection (0.3 ,uL of
- 14,000 ppm
solution) routes ofadministration were employed in the Drosophila assay. Approximately 11,000 individual
crosses with an equal number of negative controls were performed for each route of administration.
diEGBE produced no increase in recessive lethals under these conditions. We conclude that the weak
response in the mouse lymphoma assay does not have mutagenic significance because ofthe clear negative
obtained in the in vivo assay which detects the same types of mutations in germinal cells.
Introduction
The mutagenic potential of diethylene glycol mono-
butyl ether (diEGBE) was examined with a Tier I
battery of in vitro assays followed by a Tier II in vivo
Drosophila sex-linked recessive lethal assay. The in
vitro battery was designed to measure point mutations
in prokaryotes (Salmonella mutagenicity assay) and
eukaryotes (L5178Y mouse lymphoma assay). The bat-
tery also measures changes at the chromosome level (in
vitro cytogenetics with CHO cells) and nonspecific DNA
damage as measured by unscheduled DNA synthesis
(UDS) in primary cultures of rat hepatocytes.
CH2-CH2-O-CH2-CH2
OH 0-CH2-CH2-CH2-CH3
We feel that these four in vitro tests provide an
adequate measure of mutagenic potential. However,
occasionally isolated positive results are obtained with
the Tier I battery, and it is necessary to perform in vivo
Tier II testing to add perspective to these results. Our
Tier II battery is designed to detect similar types of
mutations in germinal tissues. Thus, positives in either
the Salmonella mutagenicity assay or the mouse lym-
phoma assay are resolved by performing the sex-linked
recessive lethal assay in Drosophila. Positives in the
cytogenetic or UDS assays are resolved by performing
in vivo cytogenetic assays in bone marrow, or alkaline
elution assays in germinal tissues of rodents, respec-
tively. The results ofthe Tier I battery ofmutagenicity
assays and a Drosophila sex-linked recessive lethal
assay on diEGBE are presented in this communication.
Materials and Methods
dIEGBE
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Materials
Diethylene glycol monobutyl ether was obtained from
Union Carbide Chemical Co. as Butyl Carbitol, Lot
#S767216.THOMPSON ET AL.
Salmonella Mutagenicity Test
The plate incorporation mutagenicity assay with and
without an Aroclor-induced Sprague-Dawley rat liver
S-9 fraction was performed as described by Ames et al.
(1). A preliminary toxicity assay was performed with
strain TA100 in order to determine an appropriate dose
range. Toxicity was estimated by examining the back-
ground lawn with a stero microscope over a wide range
of doses. As toxicity increases, the density of the
microcolonies decreases while their size increases with
respect to the negative control. Toxicity was also
estimated by plating approximately 300 viable cells of
TA100 onto minimal medium. The cells were suspended
in the top agar normally used except it contained 10 x
histidine which permits normal growth. A decrease in
the number of colonies appearing after 48 hr ofincuba-
tion relative to the negative control is the measure of
toxicity.
L5178Y Mouse Lymphoma Assay
L5178Y TK+'- 3.7.2C cells were obtained from Dr.
DonaldClive, Burroughs-Wellcome Co., ResearchTrian-
gle Park, NC. The cells were maintained and cleansed
ofspontaneous TK7--mutants biweekly as described by
Clive et al. (2). Mutagenicity tests were performed with
and without Aroclor-induced Sprague-Dawley rat liver
S-9 activation (2). A 2-day expression period was used
to detect mutation at the TK locus.
Unscheduled DNA Synthesis Assay in
Primary Cultures of Rat Hepatocytes
Primary cultures ofrat hepatocytes were prepared by
using the collagenase perfusion technique described by
Williams et al. (3). Sprague-Dawley rats (Charles
River) of approximately 200 g were used for each
preparation. Hepatocyte yield averaged 2 x 108 viable
cells. Overall viability averaged 91% on the basis of
trypan blue exclusion. Hepatocytes were seeded onto 25
mm diameter sterile plastic coverslips in eight-well
tissue culture plates containing Williams medium E
supplemented with 10% (v/v) fetal bovine serum and
penicillin and streptomycin. After a 1.5 to 2 hr attach-
ment period (at37°C in an atmosphere of5% CO2in air),
unattached cells were removed by gently washing.
Preliminary toxicity tests were performed on allmateri-
als before UDS assays were conducted. The test chemi-
cal in a wide range of doses was added to hepatocyte
cultures along with 10 ,uCi/mL of 3H-thymidine (New
England Nuclear, 20 Ci/mmole). After overnight incu-
bation, cultures were washed and viability was deter-
mined on the basis of trypan blue exclusion. UDS
assays were performed over a more narrow dose range.
After exposure to the test material and 3H-thymidine,
the cultures were processed forlightmicroscope autora-
diography and UDS determination (4,5).
At least 50randomly chosen, normal-appearing hepa-
tocytes were scored for UDS by counting the darkened
silver grains localized over the nucleus. All scoring was
done with an Artek 880 electronic counter equipped
with an auxiliary TV camera and Zeiss standard
microscope with a 100 x oil emersion objective. Net
incorporation of3H-thymidine into a nucleus was deter-
mined by subtracting the mean grain count of three
nucleus-sized areas adjacent to the nucleus.
In Vitro Cytogenetics Assay
with CHO Cells
The methods used for the assay for induction of
chromosome aberrations in CHO cells were a modifi-
cation of those described by Natarajan et al. (6). CHO
cells were obtained from the American TIype Culture
Collection and were maintained in Ham's F12 medium
(GIBCO) supplemented with 10% (v/v) fetal bovine
serum (Reheis). In each assay, cells were treated in
suspension with the test material or test material plus
S-9 mix for 4 hr at 37°C with constant, gentle agitation.
S-9 mix consisted of one part rat liver homogenate
prepared from 200 to 300 g Sprague-Dawley rats
induced 5 days prior to sacrifice with an intraperitoneal
injection of Aroclor 1254 combined with 2 parts of a
cofactor solution prepared in Ham's F-12 medium with-
out serum. The cofactor solution contained glucose-
6-phosphate (7.1 mM), MgC12 (7.1 mM) and NADP (5.7
mM). The cofactor solution was adjusted to pH 7.0 with
NaOH or HCl. Doses for the cytogenetics assay were
chosen on the basis of a preliminary toxicity assay. The
toxicity assay consisted ofa determination ofthe effects
ofa wide range oftest material on the plating efficiency
ofCHO cells following a4-hr exposure with and without
S-9.
In the cytogenetic assay, the cells were washed
following exposure to test material, seeded into T25
culture flasks, and incubated approximately 16 hr at
37°C. Cultures were then exposed to 2 ,ug/mL colcemid
for 2 hr to arrest cells in metaphase. Mitotic cells were
selectively dislodged by striking the side ofthe culture
flask with the palm of the hand. Suspended cells were
collected by centrifugation, resuspended in 0.075 M KCl
and incubated 4 min at room temperature. Cells were
again collected by centrifugation and fixed by slowly
resuspendingtheminCarnoy'sfixative (methanol:glacial
acetic acid, 3:1). Cells were then centrifuged and
resuspended in fresh fixative and stored overnight at
4°C. The following day, the fixed cells were centrifuged,
resuspended in Carnoy'sfixative, dropped on aninclined
microscope slide, and dried. Slides were then coded and
scored for chromosome number and aberrations. In
each experiment the top three doses showing less than
90% relative toxicity were scored. A total of 50
metaphase spreads per dose were evaluated.
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Drosophila Sex-Linked Recessive
Lethal Assay
The Drosophila sex-linked recessive lethal assay has
been described in detail by Wurgler et al. (7). In this
study wild-type Canton S males were dosed either by
feeding in a 5% sucrose vehicle buffered to pH 6.8 with
phosphate buffer or by injection with a 0.7% NaCl
solution.
Feeding was done in shell vials containing a glass
fiber filter (Whatman g F/A) saturated with 0.2 mL of
the feeding solution. One-day-old males were placed in
the vials and transferred to new treatment vials daily
for 3 days. Each treatment vial contained 0.2 mL of
freshly prepared feeding solution. Negative control flies
were fed by the same procedure on 5% sucrose buffered
to pH 6.8 with phosphate buffer. Dimethylnitrosamine
(25 ppm in the feeding and 500 ppm in the injection
study) was the positive control compound forthis study.
Injection was done with a glass needle attached by
polyethylene tubing to a Hamilton 5-,uL syringe. The
plunger was moved by a micrometer so that approxi-
mately 0.3 ,uL was injected into the body of the
etherized fly. A single injection was performed, and the
flies were allowed to recover on regular culture medium
for 24 hr before mating.
Following dosing, the wild-type Canton S males were
individually mated for 3 days with three virgin Basc
females, whose X chromosomes carry inversions and
are marked with apricot eye and bar eye. The females
were 3 to 10 days old when mated. After 3 days, each
male was transferred to three new virgin females. After
2 days the males were again transferred to vials with
three new virgin females. Two days laterthe males were
discarded. Each group of females was allowed to lay
eggs for 4 days and then they were discarded. This type
ofmating scheme examines only postmeiotic germ cells
corresponding roughly to mature sperm (brood 1),
spermatid (brood 2), and spermatocyte (brood 3).
The cultures from each brood were maintained for
approximately 10 days, then brothers and sisters were
mated individually. Approximately 33 F1 matings were
performed from each brood for each male. Thus, 99
chromosomes were examined from each dosed male.
The F2 generation was scored when the cultures were
11 to 15 days old for the absence of the wild-type X
chromosome in the male. Suspected lethal cases were
retested by mating the heterozygous female with the
males from the F2 cross and observing the F3
generation.
The recessive lethal data were evaluated by compar-
ing the overall mutation frequency of each treated
group with the overall mutation frequency ofits concur-
rent negative controls, by applying the Kastenbaum-
Bowman test (8).
When individual P1 males produced more than one
lethal among his progeny, the group of lethals is
referred to as a "multiple." A multiple may result from
many independent mutations in the post-micotic germ
cells (as is the case with a potent mutagen) or from a
single spontaneous mutation in a gonial cell, which then
multiplies to produce a cluster- of germ cells, each
carrying an identified recessive lethal mutation. Thus,
each multiple must be subjected to analysis to deter-
mine whether or not it could be considered a "cluster."
The statistical test is based on a cumulative Poisson
distribution as described by Owen (9). Given the num-
ber of lethals in the multiple, the average number of
lethals per male, and the number of fertile males, the
probability for independent events is calculated. If a
multiple is concluded to be a cluster, those data are
removed from the data.
Results
Salmonella Mutagenicity Test
Table 1 shows the results of the toxicity assay for
strain TA100. At 20 ,uL/plate, diEGBE produced a
slight depression in both the viable counts and the
background lawn. Thus, the assay was performed at a
dose which did produce noticeable toxicity. Table 2
shows the results of the Salmonella mutagenicity test.
Dose-related responses were not obtained with any of
the strains either in the presence or absence of the
S-9 activation system. All positive controls produced
at least a 5-fold increase over the spontaneous muta-
tion rate.
L5178Y Mouse Lymphoma Assay
diEGBE was tested forthe induction offorward muta-
tions in L5178Y mouse lymphoma cells over a dose
Table 1. Preliminary toxicity assay for diEGBE
with Salmonella tester strain TA100.
Concentration, Viable counts Background
,LL/plate per platea bacterial lawnb
Negative control 343 1
(50 FL H20)
0.003 296 1
0.01 296 1
0.03 308 1
0.1 392 1
0.3 314 1
1.0 289 1
3.1 228 1
10 149 2
20 55 2
aViable counts are determined by plating an appropriately diluted
culture of TA100 onto minimal medium. The overlay agar contains
lOx histidine which allows the cells to grow normally.
bSubjective evaluation of the density of the background bacterial
lawn when viewed through a stereo microscope at approximately 40 x
magnification. A 1 respresents a normal bacterial lawn. A 2 repre-
sents a slightly reduced bacterial lawn: 15-25% thinning of the
microcolonies which is accompanied by an increase in size of the
microcolonies compared to the negative control.
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Table 2. Results of the Salmonella mutagenicity test on diEGBE.a
diEGBE Concentration,
units/plate
Negative control
Solvent control
(50 F.L H20)
0.2 ,LL
1.0 FL
5.0 ,uL
10,LO
20 ILL
TA1535
No S-9 With S-9 No S-9
26 ± 3 17 ± 2 187 ± 15
27 ± 3 17 ± 4 177 ± 16
27 ± 5 22 ± 1 178 ± 19
27 ± 4 16 ± 1 184 + 17
25 ± 3 23 ± 2 168 ± 5
32 ± 5 17 ± 6 189 ± 18
28 ± 6 10 ± 3 189 ± 24
No. of revertant coloniesa
TA100 TA1537 TA1538 TA98
With S-9 No S-9 With S-9 No S-9 With S-9 No S-9 With S-9
i 181 ± 10 6 ± 2 10 ± 5 12 ± 5 16 ± 7 26 ± 2 40 ± 3
177 ± 7 6 2 8 ± 3 5 ± 1 18 + 7 23 ± 5 36 ± 3
185 + 9
176 + 10
154 ± 21
165 ± 13
152 ± 5
7 ± 4 7 ± 3 8 ± 3 20 ± 3 25 ± 4 35 ± 6
4 ± 2 9 ± 3 6 ± 2 16 + 4 25 ± 5 31 ± 6
5 ± 3 8 ± 4 9 ± 3 14 ± 7 25 ± 3 33 ± 2
9 ± 4 8 ± 4 7 ± 2 17 ± 5 30 ± 7 30 ± 6
8 ± 2 4 ± 1 7 ± 1 11 ± 3 21 ± 4 28 ± 1
Positive controls
2-Aminoanthracene
1 iLg 1304 + 113 780 81 552 27
4 p.g 203 39 433 35
2-Nitrofluorene, 10 p.g 1865 223 - 1460 ± 83
1,3-Propane sultone,
0.04 ,uL 1593 ± 70 1514 ± 76
9-Aminoacridine,
75p.Lg 735 ± 163
aTests were performed in the absence of the S-9 metabolic activation system or in the presence of the S-9 metabolic activation system. Each
number is the average number of revertant colonies on three plates with the standard deviation.
Table 3. Results of the L5178Y TK+'- mouse lymphoma assay on diEGBE.
Metabolic Relative suspension Relative plating Relative total Mutation Relative increase
Concentration, activation growth, % of efficiency, % of growth, % of frequency over solvent
pL/mL ( + or - ) solvent control solvent control solvent control ( x 106) control
Solvent control ( - ) 100 100 100 40
diEGBE
0.42 ( - ) 99 113 112 30 0.75
0.56 (-) 99 106 105 20 0.5
0.75 ( - ) 94 116 108 30 0.75
1.0 (-) 87 116 101 40 1.0
1.3 (-) 83 111 92 40 1.0
1.8 (-) 84 107 90 50 1.25
2.4 (-) 71 101 72 40 1.0
3.2 (-) 60 104 62 70 1.75
4.2 (-) 25 89 22 150 3.75
5.6 (-) 13 92 12 180 4.5
7.5 (-) 0
EMS
0.5 (-) 47 42 20 1000 25
1.0 (-) 21 8 2 2000 50
Solvent control ( + ) 100 100 100 50
diEGBE
0.56 (+) 96 92 89 50 1.0
0.75 (+) 100 104 105 50 1.0
1.0 (+) 96 93 89 50 1.0
1.3 (+) 94 101 95 60 1.2
1.8 (+) 97 103 100 50 1.0
2.4 (+) 93 104 97 50 1.0
3.2 (+) 97 90 87 40 0.8
4.2 (+) 86 91 78 60 1.2
5.6 ( + ) 81 Contaminated Contaminated Contaminated Contaminated
7.5 (+) 69 84 58 50 1.0
10.0 (+) 0
7, 12-Dimethylbenz-
(a)anthracene
5.0 ,ug/mL ( + ) 76 62 68 400 5.7
7.5,ug/mL (+) 46 90 20 590 8.4
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range of 0.42 [uL/mL to 5.6 iuL/mL in the absence of
metabolic activation and over a dose range of 0.56
,iL/mL to 7.5 ,uL/mL in the presence of metabolic
activation. The maximal toxicity achieved was 88% kill
in the absence ofmetabolic activation and 42% kill inthe
presence ofthe activation system. The next higher dose
(10 ,uL/mL) in the latter assay produced 100% toxicity.
Thus, diEGBE was tested throughout a range of
toxicities (Table 3). When the cells were plated in
selective medium, a weak, but dose-related response
was obtained in the absence of metabolic activation.
diEGBE was negative in this assay in the presence of
the metabolic activation system (Table 3).
UDS in Rat Hepatocytes
Results of the UDS assay in rat hepatocytes are
shown in Table 4. diEGBE did not induce UDS in these
cells through a suitable range of toxicities.
Table 4. Results of the unscheduled DNA synthesis assay
in primary cultures of rat hepatocytes on diEGBE.
Mean net nuclear grain Approximate %
Dose, count (standard error survival relative to
,uL/mL of the mean) solvent control
0 3.0 (1.4)
0.26 0.9 (1.3) 93
0.39 0.3 (0.8) 98
0.58 - 0.5 (1.3) 106
0.87 - 0.1 (1.2) 92
1.32 2.8 (1.5) 102
1.97 - 1.1 (0.9) 96
2.96 - 0.9 (1.0) 96
4.44 3.4 (1.0) 59
6.67 a 32
10.0 a 2
25 ,ug/mL DMBA 168.3 (13.2) 55
aNot scored due to excessive toxicity.
In Vitro Cytogenetics Assay in CHO Cells
Results ofthetoxicity assayfortheinvitro cytogenet-
ics assay in the presence and absence of a S-9 metabolic
activation system are shown in Table 5. Both assays
were performed over a dose range that produced
toxicity. However, in the presence of the activation
system the toxicity curve appears much steeper.
Cytogenetic analyses of the three highest doses
showing less than 90% toxicity are shown in Table 6.
diEGBE was not clastogenic to these cells.
Sex-Linked Recessive Lethal Assay in
Drosophila
Preliminary toxicity assays indicated that 14,000 ppm
was a suitable dose level for the injection portion ofthe
assay (average of36% mortality 24 hr afterthe dose was
administered). The preliminary toxicity assay for the
feeding experiment was complicated apparently by the
humidity in the dosing room. Table 7 shows the results
of five preliminary toxicity assays, some performed
under dry room conditions and some performed under
humid conditions. These data clearly show that at least
for diEGBE the relative humidity greatly affects the
dose tolerated by the flies. It is believed that the flies
simply ingest less under humid conditions (Ruby
Valencia, personal communication). Based on these
assays 11,000 ppm was selected for the feeding studies.
Results of the injection and feeding portions of the
sex-linked recessive lethal assay are shown in Tables 8
and 9, respectively. Approximately 11,000 chromosomes
were examined in the injection and feeding studies with
an equal number examined in the concurrent controls.
Thus, a total of 44,000 chromosomes were examined in
this study. diEGBE did not induce sex-linked recessive
lethal mutations in this assay.
Table 5. Results ofthe toxicity assay on diEGBE for the in vitro cytogenetics assay with CHO cells in the presence and absence of a S-9
metabolic activation system.
No S-9 With S-9
diEGBE No. cells Relative diEGBE No. cells Relative
concentration, seeded per No. colonies cloning concentration, seeded per No. colonies cloning
,uL/mL plate per plate efficiency ,uL/mL plate per plate efficiency
Negative control 200 68 91 Negative control 200 89 93
Solvent control 200 66 100 Solvent control 200 96 100
1.06 200 53 80 1.88 200 91 95
1.41 200 50 76 2.51 200 38 40
1.88 200 44 67 3.34 200 78 81
2.51 200 33 50 4.46 200 65 68
3.34 200 27 41 5.94 200 80 83
4.46 200 35 53 7.92 200 81 84
5.94 200 18 27 10.56 200 2 2
7.92 200 16 24
Positive control, Positive control,
triethylene- cyclophosphamide,
melamine, 200 34 51 35 ,ug/mL 200 15 16
0.5 ,ug/mL
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Table 6. Results of the in vitro cytogenetics assay with CHO cells on diEGBE in the presence and absence
of a S-9 metabolic activation system.a
diEGBE
concentration, Chromatidb Chromatid Chromosome Frag- Dicen- Exchange Pulver- > 10 Aber- Poly- Aberrations
,uL/mL gaps breaks breaks ments trics Rings figures ized rations ploid per cell'
Negative
control 2 1 3 1 3 0.16
Solvent control 1 2 2 1 4 0.20
4.46 1 2 2 1 3 0.16
5.94 1 1 2 4 1 - 5 0.26
7.92 4 1 4 1 1 - - 3 0.20
TEM,
0.5pkg/mL 3 16 11 10 2 3 35 2 8 5 3.28
Negative
controld 1 1 1 - - 5 0.14
Solvent
controld 1 1 1 3 0.16
4.46d 1 2 2 2 1 - 5 0.24
5.94-d 1 2 1 6 0.2
7.92d 1 2 5 3 0.2
Cyclophos-
phamide,
35 ILg/mLd 4 11 4 15 2 - 26 1 3 4 1.80
'A total of 50 cells was scored in each test.
bChromatid gaps are recorded, but included in the aberrations per cell calculation.
cEach aberration type is given an arbitrary weight of one except pulverized and > 10 aberrations which are weighted as 10.
dTested with S-9 metabolic activation system.
Table 7. Results of preliminary toxicity assays on diEGBE
in Drosophila.
diEGBE concentration,
ppm
11,000
10,000
8,000
11,000
5,500
1,100
11,000
9,000
7,000
5,000
3,000
1,000
11,000
5,000
1,000
11,000
5,000
1,000
11,000
9,000
5,000
1,000
11,000
5,000
1,000
Mortality
at 72 hr, %
33
2
14
100
100
19
80 (27 hr)
100 (27 hr)
73 (27 hr)
67 (27 hr)
88 (27 hr)
66 (68 hr)
0 (24 hr)
0 (24 hr)
0 (24 hr)
100 (24 hr)
100 (24 hr)
0 (24 hr)
0
2
1
2
97 (24 hr)
100 (24 hr)
99 (72 hr)
Conclusions
The results of three of the in vitro assays, the
Salmonella mutagenicity test, the cytogenetics assay in
CHO cells, and the UDS assay in rat hepatocytes, were
straightforward negatives. Each assay was performed
either at the limits oftoxicity to the cells or at the limit
of compound that could be added to the test system.
Decreasing doses from this level provided an adequate
number of data points to ensure that any possible
dose-response would have been detected.
The mouse lymphoma assay presented conflicting
results. In the absence of the S-9 metabolic activation
system, a dose-related increase was obtained with the
highest response being approximately 5-fold above the
background level. In the presence of the S-9 metabolic
activation system the compound was negative. It should
be emphasized here that the response obtained in
the absence of S-9 is relatively weak on a molar
basis. One ,umole ofdiEGBE induced 1.1 mutations/106
survivors/hr of exposure at 10% survival compared to
812 for methyl methanesulfonate or 1.8 x 106 for
N-methyl-N-nitro-N-nitrosoguanidine at the same rela-
tive toxicity (2).
The negative results in the presence of the S-9
activation system indicates that the mutagenic com-
pound may be metabolized to a nonmutagenic
compound. Such inactivation suggests that the com-
pound would be metabolized in an in vivo test system
and would be negative.
The sex-linked recessive lethal assay was run to
Assay
1
2
3
4 (Humid)
(Dry)
5 (Humid)
(Dry)
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Table 8. Results of the injection route of administration (14,000 ppm) in the Drosophila sex-linked recessive lethal assay on diEGBE.
Number of lethals/number of tests
Brood 1 Brood 2 Brood Total Number of lethals
Experiment (days 1-3) (days 4-5) (days 6-7) lethal tests Multiplesa Singles Percent lethals
Butyl carbitol
1 0/1883 3/1678 1/1763 5,324 0 4 0.075
2 3/1272 3/1147 3/1010 3,429 1(7) 2 0.262b
2-Less multiple 1(7) 2/1239 0/1114 0/977 3,330 0 2 0.60
3 6/789 11/740 8/686 2,215 1(25) 0 1.13
3-Less multiple 1(25) 0/756 0/707 0/653 2,116 0 0 0
4 0/132 0/132 1/128 392 0 1 0.255
Total 2/4010 3/3631 2/3521 11,162 0 7 0.063
Negative control
1 1/2026 8/1958 1/1760 5,744 1(6) 4 0.174b
1-Less multiple 1(6) 0/1993 3/1925 1/1768 5,678 0 4 0.07
2 0/725 0/664 0/674 2,063 0 0 0
3 3/1153 5/1077 1/1075 3,305 1(7) 2 0.272
3-Less multiple 1(7) 1/1120 1/1044 0/1042 3,206 0 2 0.062
4 0/128 0/132 0/130 390 0 0 0
Total 1/3966 4/3765 1/3606 11,337 0 6 0.053
Positive control
DMN (500 ppm) 15/460 40/489 75/390 1,339 1(2) 1(4) 0 9.71
1(5) 2(7)
2(8) 1(9)
3(10) 1(12)
1(13) 1(19)
Less multiple 1(19) 13/427 29/456 69/359 1,242 8.94
aMultiples may be derived from spontaneous mutations in gonia cells. Since these cells continue to divide, mutations occur in multiples. Each
multiple is analyzed statistically (9), and if found significant the data derived from that P1 male are removed.
bThe percent lethals are high because of a multiple. These data are not used in the final calculations.
Table 9. Results of the oral route of administration (11,000 ppm) in the Drosophila sex-linked recessive lethal assay on diEGBE.
Number of lethals/number of tests
Brood 1 Brood 2 Brood Total Number of lethals
Experiment (days 1-3) (days 4-5) (days 6-7) lethal tests Multiplesa Singles Percent lethals
Butyl carbitol
1 2/2180 10/2136 8/2124 6,440 1(16) 4 0.31lb
1 Less multiple 1(16) 0/2147 2/2103 2/2091 6,341 0 4 0.063
2 2/2296 3/2184 2/1987 6,467 0 7 0.108
Total 2/4443 5/4287 4/4078 12,808 0 11 0.086
Negative control
1 2/1822 0/1620 0/1605 5,047 0 2 0.040
2 2/2105 2/2022 5/1979 6,106 1(2) 4 0.147b
1(3)
2 Less multiple 1(3) 1/2072 2/1989 3/1961 6,022 1(2) 4 0.010
Total 3/3894 2/3609 3/3566 11,069 1(2) 6 0.072
Positive control, DMN,
25 ppm 7/651 34/615 27/557 1,843 3(2) 6(3) 3 3.69
5(4) 2(6)
1(9)
aMultiples may be derived from spontaneous mutations in gonia cells. Since these cells continue to divide, mutations occur in multiples.
Each multiple is analyzed statistically (9), and if found significant the data derived from that P1 male are removed.
bThe percent lethals are high because of a multiple. These data are not used in the final calculations.
resolve the question ofmutagenic activity in an in vivo
system. Since this assay measures the transmittance of
mutation in germinal tissue to future generations, it
provides information as to the potential genetic burden
of a mutagen. More than 44,000 chromosomes were
examined in the two tests and the results were conclu-
sively negative. Statistical evaluation of these data
indicate 95% confidence that diEGBE would produce
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less than a 0.2% increase in the mutation frequency. A
0.2% increase in the mutation frequency is the maximal
power of the sex-linked recessive lethal assay.
Based on the three negative in vitro assays, a very
weak positive in the mouse lymphoma assay and a
conclusive negative in the in vivo assay, we conclude
that diEGBE does not present any genetic risk to
humans.
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